Tiptree to sell Fortegra for $1.65B and Reliance for $50M; controls disclosures absent

Filed April 30, 2026 · Period ending March 31, 2026 · Compared to 10-Q Apr 30, 2025 · ~2 min read

Key Changes

• high

  Tiptree signed definitive agreements to sell Fortegra for $1.65B cash (expected $1.1B net to Tiptree, $410M gain) and Reliance for ~$50M, with closings expected mid-2026. Both now classified as discontinued operations, fundamentally restructuring the company into a holding company with $75M debt that must be repaid from Fortegra proceeds.

  MD&A: Fortegra and Reliance Sales verify on EDGAR →
• high

  Required quarterly certifications of disclosure controls effectiveness and internal control changes are absent from current filing, despite being present in all prior periods. No explanation provided for the omission of these standard SEC-required disclosures.

  Controls and Procedures verify on EDGAR →
• high

  Detailed disclosure added for 20-year-old Mullins class action involving credit insurance sold 1997-2007. Kentucky Supreme Court denied review in Feb 2025, returning case to trial court after mixed appellate ruling. Company cannot estimate loss range but notes credit insurers have faced large punitive awards.

  Legal Proceedings verify on EDGAR →